Frequency of<i>BRAF</i>Mutation and Clinical Relevance for Primary Melanomas
Hyoun Wook Lee(Samsung (South Korea)), Dae Cheol Kim(Taiwan Livestock Research Institute), Sung Hyun Kim(Celltrion (South Korea)), Ki‐Ho Kim(Dong-A University), Jin Woo Hong(Eulji University), Su Young Jeon(Dong-A University), Ki Hoon Song(Dong-A University), Hyuk Chan Kwon, Dong Yeob Ko(Dong-A University), Suee Lee(Dong-A University)
Cited by 14
Related Papers
Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.
|PubMed|2011|77
Absolute Quantitation of DNA Methylation of 28 Candidate Genes in Prostate Cancer Using Pyrosequencing
|Disease Markers|2011|73
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection
|Clinical Therapeutics|2021|47
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019
|Open Forum Infectious Diseases|2022|42
Prognostic Role of Methylation Status of the<i>MGMT</i>Promoter Determined Quantitatively by Pyrosequencing in Glioblastoma Patients
|Journal of Korean Neurosurgical Society|2016|36